Case Control Study
Copyright ©The Author(s) 2020.
World J Diabetes. Feb 15, 2020; 11(2): 42-51
Published online Feb 15, 2020. doi: 10.4239/wjd.v11.i2.42
Table 2 Clinical and biochemical features of the polycystic ovary syndrome subjects with and without insulin resistance
ParametersPCOS IR+ (n = 28)PCOS IR- (n = 44)P value
Age (yr)25.07 ± 5.6723.98 ± 4.890.388
Menarche age (yr)12.71 ± 2.0313.14 ± 1.850.367
Ferriman-Gallwey Score8.04 ± 6.919.00 ± 5.870.528
Systolic blood pressure (mm Hg)114.08 ± 22.20106.59 ± 13.430.087
Diastolic blood pressure (mm Hg)74.62 ± 17.4270.32 ± 11.890.232
BMI (kg/m²)27.39 ± 6.2723.90 ± 4.660.016
WC (cm)90.09 ± 15.7680.58 ± 11.360.008
WHR0.84 ± 0.070.80 ± 0.060.014
WHtR0.54± 0.090.49 ± 0.070.014
Dominant wrist circumference (cm)16.49 ± 1.2715.66 ± 0.950.005
Non-dominant wrist circumference (cm)16.33 ± 1.2015.45 ± 1.030.002
Weight (kg)72.88 ± 18.5663.26 ± 13.860.025
Body fat (%)38.50 ± 9.4432.93 ± 9.220.017
Muscle (%)26.30 ± 3.4226.90 ± 5.090.591
Visceral fat5.48 ± 2.154.16 ± 1.750.010
Glucose (mg/dL)93.04 ± 10.3482.36 ± 7.99< 0.001
Insulin (µU/L)26.22 ± 19.997.71 ± 2.99< 0.001
HOMA-IR (mol × µU/L²)6.26 ± 5.321.57 ± 0.63< 0.001